～国際学会 2012 年度～

European Congress of Radiology 2012 Vienna 2012.3.1-5
Imaging of congenital cytomegalovirus infection (CCMVI)Oda M, Kitajima K, Konishi J, Iwama Y, Fujii M, Sugimura K, Morioka I, Iijima K,
Tanimura K, Yamada H.
Pediatric Academic Societies Annual Meeting Boston 2012.4.28-5.1
Survey of outcome and safety with oseltamivir treatment in Japanese infants under 3 months ofage with influenza.
Morioka I, Nonoyama S, Tanaka-Taya K, Ihara T, Sugaya N, Ueta I, Kumagai T, Okada K,Hosoya M, Okabe N, Morishima T.
Correlation and precision of serum free bilirubin concentrations in term or late-pretermnewborns determined by single and two peroxidase concentration methods using a
FDA-approved analyzer.
Miwa A, Morioka I, Koda T, Matsuo K, Yokota T, Fujioka K, Morikawa S, Shibata A,
Yokoyama N, Nakamura H, Iijima K.
Ventricular dilatation is associated with abnormalities of auditory brainstem response in infants
with congenital cytomegalovirus infection.
Matsuo K, Morioka I, Oda M, Koda T, Yokota T, Fujioka K, Morikawa S, Miwa A, Shibata A,
Tanimura K, Enomoto M, Kobayashi Y, Nakamachi Y, Kawano S, Yokoyama N, Yamada H,Iijima K.
Vascular endothelial growth factor genetic polymorphisms in newborns with intrauterine
growth restriction.
Fujioka K, Morioka I, Yagi M, Koda T, Matsuo K, Yokota T, Morikawa S, Miwa A, Shibata
A, Yokoyama N, Takeshima Y, Yamada H, Iijima K.
Dystrophin Gene Mutations in Three Dystrophynopathy Patients with Severe Cardiomyopathy.
Awano H, Lee T, Yagi M, Takeshima Y, Matsuo M, Iijima K.
Japan-Korea The 10th Pediatric Nephrology Seminar 2012 Tokyo
Genetic approaches in pediatric nephrology.
Iijima K.

2012.5.12-13

Hyponatremic Hypertensive Syndrome in an Infant Child Presenting as Nephrotic Syndrome:a Case Report.
Ninchoji T, Kaito H, Otsubo H, Hashimoto F, Ishimori S, Hashimura Y, Morisada N,
Kawasaki A, Yamaguchi M, Iijima K.
8th Congress of Asian Society for Pediatric Research Conference Seoul 2012.5.17-19
Impact of pre-emptive contact precautions for outborn patients on the incidence of nosocomial
MRSA transmission in a Japanese neonatal intensive care unit.
Morioka I, Shibata A, Miwa A, Yokoyama N, Yahata M, Lee M, Yoshida H, Arakawa S,Yamada H, Iijima K.
the Advances in Neuroblastoma Research 2012 Conference Toronto 2012.6.18-21
Rab15 alternative splicing correlates with differentiation of neuroblastoma cells.
Hartomo TB, Pham TV, Hasegawa D, Kosaka Y, Hayakawa A, Takeshima Y, Iijima K,
Matsuo M, Nishio H, Nishimura N.

Department of Pediatrics, Kobe University Graduate School of Medicine

～国際学会 2012 年度～

Minimal residual disease monitoring in neuroblastoma patients by a set of real-time RT-PCRmarkers.
Tanaka A, Hasegawa D, Hartomo TB, Ishida T, Kawasaki K, Kosaka Y, Iijima K, Matsuo M,Nishio H, Nishimura N.
The 20th World "INTERNATIONAL ASSOCIATION FOR CHILD AND ADOLESCENTPSYCHIATRY AND ALLIED PROFESSIONS(IACAPAP) Congress” Paris 2012.7.21-25
Changes of behavioral problems of children at a children’s home in Japan, accompanied by thedownsizing.
Tanaka K, Mandai T, Iwamoto N, Matsui Y, Kitayama S, Honaga E, Tamaoka A, HishimotoA.
45th Annual Scientific Meeting of the European Society for Pediatric Nephrology Krakow
2012.9.6-8
Clinicopathological characteristics and kidney outcome of childhood-onset lupus nephritis withacute kidney injury: from the multicenter study in Japan.
Ishimori S, Kaito H, Otsubo H, Hashimoto F, Ninchoji T, Hashimura Y, Kamioka I, Shima Y,
Hamahira K, Nakanishi K, Tanaka R, Yoshikawa N, Iijima K.
23rd Congress of the Asian Association of Pediatric Surgeons Seoul 2012.10.8-10
Intraventricular hemorrhage as a risk factor for intestinal obstruction in very low birth-weight
infants.
Hisamatsu C, Okata Y, Matsuo K, Morioka I, Iijima K, Nishijima E.
14th International CMV/BetaHerpesvirus Workshop San Francisco 2012.10.29-11.2
A Follow-up Study of Japanese Infants with Congenital CMV Infection.
Morioka I, Koyano S, Moriuchi H, Oka A, Ito Y, Yoshikawa T, Asano K, Inoue N,Yamada H, for the Japanese Congenital Cytomegalovirus Study Group
Awareness and Knowledge of CMV Infection in Japanese Pregnant Women.
Morioka I, Sonoyama A, Tairaku S, Tanimura K, Ebina Y, Iijima K, Yamada H.
Prevalence of Serological Screening of Cytomegalovirus Infection for Pregnant Women in
Japan: A Nationwide Survey.
Tairaku S, Tanimura K, Ebina Y, Sonoyama A, Nagamata S, Morioka I, Yamada H.
Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection.
Ebina Y, Sonoyama A, Morioka I, Tanimura K, Morizane M, Tairaku S, Minematsu T, Inoue
N, Yamada H.
American Society of Nephrology, 2012 Kidney Week San Diego 2012.10.30-11.4
Clinical characteristics and mutational pattern of genetically-proven Gitelman’s syndrome.
Ninchoji T, Kaito H, Nozu K, Nakanishi K, Yoshikawa N, Iijima K.
Genetical and clinical aspects of X-linked Alport syndrome in males with positive staining ofthe α5 (IV) chain.
Hashimura Y, Nozu K, Kaito H, Ishimori S, Otsubo H, Hashimoto F, Ninchoji T, Morisada N,Nakanishi K, Yoshikawa N, Iijima K.
Histological Predictors of Treatment Efficacy in Severe Childhood IgA Nephropathy (IgAN):
Validation of the Oxford Classification of IgAN (Ox C).
Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Ishimori S, Kaito H, Tanaka R,Iijima K, Yoshikawa N.

Department of Pediatrics, Kobe University Graduate School of Medicine

～国際学会 2012 年度～

Multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment ofchildhood-onset refractory nephrotic syndrome.
Iijima K, Sako M, Tuchida N, Ohashi Y.
A novel UMOD mutation in a family with medullary cystic kidney disease type 2.
Kamijo M, Tamura M, Ishimatsu N, Miyamoto T, Serino R, Kabashima N, Kanegae K,
Furuno Y, Bando K, Nakamata J, Kuma A, Ishimori S, Morisada N, Iijima K, Otsuji Y.
Possible contribution of fibrocytes to renal fibrosis in Cpk mouse, a model of ARPKD.
Hama T, Nakanishi K, Mukaiyama H, Togawa H, Shima Y, Miyajima M, Takahashi H,Nagao S, Iijima K, Yoshikawa N.
Mutation analysis in Japanese patients with congenital and infantile nephrotic syndrome.
Mukaiyama H, Nakanishi K, Hama T, Togawa H, Shima Y, Iijima K, Yoshikawa N.
The American Society of Human Genetics, the 62th Annual Meeting San Francisco
2012.11.6-10
Standard value of urine HVA/VMA ratio in the early neonatal period to screen for Menkes
disease.
Yagi M, Kusunoki N, Lee T, Awano H, Yokota T, Miwa A, Shibata A, Morioka I,Takeshima Y, Iijima K.
A small chemical, TG003, enhances skipping of mutated dystrophin exons: the third example
revealing a decrease of exonic splicing enhancer density in common.
Nishida A, Takeshima Y, Kataoka N, Yagi M, Awano H, Lee T, Iijima K, Hagiwara M, Matsuo
M
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy.
Taniguchi M, Kobayashi K, Kanagawa M, Yu CC, Oda T, Kuga A, Kurahashi H, Akmen O,DiMauro S, Yokota T, Takeda S, Toda T.

Department of Pediatrics, Kobe University Graduate School of Medicine